Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
488.3
USD
|
+0.03%
|
|
+0.16%
|
+1.09%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,093
|
1,058
|
750.6
|
779.7
|
1,022
|
1,756
|
Enterprise Value (EV)
1 |
962.7
|
805.3
|
170.4
|
66.42
|
727.4
|
1,274
|
P/E ratio
|
9.36
x
|
8.04
x
|
8.13
x
|
4.32
x
|
10.1
x
|
18.6
x
|
Yield
|
0.12%
|
0.12%
|
0.17%
|
0.17%
|
0.13%
|
0.07%
|
Capitalization / Revenue
|
1.98
x
|
1.29
x
|
1.09
x
|
0.95
x
|
1.83
x
|
2.5
x
|
EV / Revenue
|
1.75
x
|
0.98
x
|
0.25
x
|
0.08
x
|
1.3
x
|
1.81
x
|
EV / EBITDA
|
6.28
x
|
4.48
x
|
1.42
x
|
0.28
x
|
5.18
x
|
9.13
x
|
EV / FCF
|
10.9
x
|
-389
x
|
-0.1
x
|
-0.08
x
|
-2.24
x
|
3.24
x
|
FCF Yield
|
9.22%
|
-0.26%
|
-991%
|
-1,201%
|
-44.7%
|
30.8%
|
Price to Book
|
0.58
x
|
0.5
x
|
0.3
x
|
0.31
x
|
0.51
x
|
0.72
x
|
Nbr of stocks (in thousands)
|
3,636
|
3,636
|
3,636
|
3,636
|
3,636
|
3,636
|
Reference price
2 |
300.7
|
290.9
|
206.4
|
214.4
|
281.0
|
483.0
|
Announcement Date
|
3/1/19
|
2/28/20
|
3/16/21
|
3/10/22
|
3/15/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
551.6
|
819.2
|
690.5
|
824.1
|
558.4
|
703.4
|
EBITDA
1 |
153.3
|
179.7
|
119.8
|
240.3
|
140.4
|
139.6
|
EBIT
1 |
141.5
|
168.5
|
107.9
|
227.3
|
126
|
129.7
|
Operating Margin
|
25.65%
|
20.56%
|
15.62%
|
27.58%
|
22.57%
|
18.44%
|
Earnings before Tax (EBT)
1 |
141.5
|
165.2
|
112.1
|
227.3
|
126
|
129.7
|
Net income
1 |
116.8
|
131.6
|
92.31
|
180.7
|
101.1
|
94.43
|
Net margin
|
21.17%
|
16.07%
|
13.37%
|
21.92%
|
18.11%
|
13.43%
|
EPS
2 |
32.11
|
36.20
|
25.39
|
49.69
|
27.82
|
25.97
|
Free Cash Flow
1 |
88.72
|
-2.071
|
-1,689
|
-797.9
|
-324.9
|
393
|
FCF margin
|
16.08%
|
-0.25%
|
-244.54%
|
-96.82%
|
-58.18%
|
55.88%
|
FCF Conversion (EBITDA)
|
57.86%
|
-
|
-
|
-
|
-
|
281.58%
|
FCF Conversion (Net income)
|
75.99%
|
-
|
-
|
-
|
-
|
416.22%
|
Dividend per Share
2 |
0.3600
|
0.3600
|
0.3600
|
0.3600
|
0.3600
|
0.3600
|
Announcement Date
|
3/1/19
|
2/28/20
|
3/16/21
|
3/10/22
|
3/15/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
131
|
252
|
580
|
713
|
294
|
482
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
88.7
|
-2.07
|
-1,689
|
-798
|
-325
|
393
|
ROE (net income / shareholders' equity)
|
6.26%
|
6.53%
|
3.97%
|
7.11%
|
4.45%
|
4.08%
|
ROA (Net income/ Total Assets)
|
0.73%
|
0.86%
|
0.5%
|
0.98%
|
0.57%
|
0.65%
|
Assets
1 |
15,946
|
15,306
|
18,626
|
18,433
|
17,612
|
14,584
|
Book Value Per Share
2 |
523.0
|
585.0
|
698.0
|
698.0
|
552.0
|
671.0
|
Cash Flow per Share
2 |
36.30
|
69.70
|
160.0
|
197.0
|
81.20
|
133.0
|
Capex
1 |
3.14
|
2.84
|
12.1
|
9.98
|
1.59
|
5.56
|
Capex / Sales
|
0.57%
|
0.35%
|
1.75%
|
1.21%
|
0.29%
|
0.79%
|
Announcement Date
|
3/1/19
|
2/28/20
|
3/16/21
|
3/10/22
|
3/15/23
|
2/29/24
|
|
1st Jan change
|
Capi.
|
---|
| +1.09% | 1.78B | | +3.05% | 95.15B | | +1.78% | 94.71B | | -20.65% | 77.24B | | +18.68% | 74.93B | | +6.69% | 30.04B | | +18.06% | 27.87B | | +4.32% | 26.97B | | -1.21% | 16.99B | | -9.10% | 15.16B |
Life Insurance
|